| Literature DB >> 27185067 |
Wen Wan1, Xin-Yan Pei2, Steven Grant2, Jeffrey B Birch3, Jessica Felthousen2, Yun Dai2, Hong-Bin Fang4, Ming Tan4, Shumei Sun1.
Abstract
Few articles have been written on analyzing three-way interactions between drugs. It may seem to be quite straightforward to extend a statistical method from two-drugs to three-drugs. However, there may exist more complex nonlinear response surface of the interaction index (II) with more complex local synergy and/or local antagonism interspersed in different regions of drug combinations in a three-drug study, compared in a two-drug study. In addition, it is not possible to obtain a four-dimensional (4D) response surface plot for a three-drug study. We propose an analysis procedure to construct the dose combination regions of interest (say, the synergistic areas with II≤0.9). First, use the model robust regression method (MRR), a semiparametric method, to fit the entire response surface of the II, which allows to fit a complex response surface with local synergy/antagonism. Second, we run a modified genetic algorithm (MGA), a stochastic optimization method, many times with different random seeds, to allow to collect as many feasible points as possible that satisfy the estimated values of II≤0.9. Last, all these feasible points are used to construct the approximate dose regions of interest in a 3D. A case study with three anti-cancer drugs in an in vitro experiment is employed to illustrate how to find the dose regions of interest.Entities:
Keywords: Genetic algorithm (GA); Interaction index (II); Model robust regression (MRR); Synergism; Three-drug combination; Viability
Mesh:
Year: 2016 PMID: 27185067 PMCID: PMC5148726 DOI: 10.1002/bimj.201500021
Source DB: PubMed Journal: Biom J ISSN: 0323-3847 Impact factor: 2.207